{"id":"W2240235803","doi":"10.1200/jco.2009.27.15_suppl.5591","title":"A phase II study of aflibercept (VEGF trap) in recurrent or metastatic gynecologic soft-tissue sarcomas: A study of the Princess Margaret Hospital Phase II Consortium","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Aflibercept; Leiomyosarcoma; Adverse effect; Bevacizumab; Internal medicine; Surgery; Phases of clinical research; Sarcoma; Gastroenterology; Oncology; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003943681,0.001595786,0.001856619,0.0005280313,0.0004713469,0.0008391152,0.001125918,0.001528168,0.003312004],"category_scores_gemma":[0.001379168,0.0006541381,0.001217012,0.0004926703,0.0008582777,0.0006593918,0.0004047733,0.002320576,0.0007898709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001030935,"about_ca_system_score_gemma":0.002062286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001605778,"about_ca_topic_score_gemma":0.002802905,"domain_scores_codex":[0.9991857,0.0004451393,0.00003767592,0.0001173247,0.00009237484,0.0001217688],"domain_scores_gemma":[0.9987223,0.0001992061,0.0002642916,0.00009650744,0.0001070604,0.0006106798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5326332,0.1477586,0.02824983,0.001528553,0.002919185,0.00119387,0.0009317559,0.004047127,0.1036212,0.0005388258,0.01017156,0.1664063],"study_design_scores_gemma":[0.5639735,0.4063118,0.02160755,0.00004024617,0.0004606519,0.0007377156,0.00006282249,0.001387981,0.002833531,0.0001288778,0.002422995,0.00003232123],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908792,0.002011626,0.0008503491,0.0004216357,0.00005242652,0.004037949,0.0006584915,0.00005796394,0.001030298],"genre_scores_gemma":[0.978999,0.002643268,0.003738603,0.001652226,0.0001950385,0.005855078,0.004018012,0.00003652402,0.002862227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003943681,"threshold_uncertainty_score":0.02085644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1095529008604727,"score_gpt":0.4744979455907162,"score_spread":0.3649450447302435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}